These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3604261)

  • 1. Metabolic oxidation of the pyrrole ring: structure and origin of some urinary metabolites of the anti-hypertensive pyrrolylpyridazinamine, mopidralazine. III: Studies with the 13C-labelled drug.
    Assandri A; Tarzia G; Bellasio E; Ciabatti R; Tuan G; Ferrari P; Zerilli L; Lanfranchi M; Pelizzi G
    Xenobiotica; 1987 May; 17(5):559-73. PubMed ID: 3604261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine+ ++ hydrochloride. I. Studies in the rat.
    Assandri A; Perazzi A; Baldoli E; Ferrari P; Ripamonti A; Bellasio E; Tuan G; Zerilli F; Tarzia G
    Xenobiotica; 1985 Dec; 15(12):1069-87. PubMed ID: 4090527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. II: Studies in the dog.
    Assandri A; Perazzi A; Bellasio E; Ciabatti R; Tarzia G; Ferrari P; Ripamonti A; Tuan G; Zerilli LF
    Xenobiotica; 1985 Dec; 15(12):1089-102. PubMed ID: 4090528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of three metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine. A new rearrangement of 3-[1-methylethyliden)hydrazino] derivative.
    Bellasio E; Campi A
    Farmaco Sci; 1978 Aug; 33(8):565-72. PubMed ID: 744255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine dihydrochloride in rat urine.
    Beretta E; Cristina T; Ferrari P; Tuan G; Zerilli LF; Martinelli E
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):29-33. PubMed ID: 38122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensives. N-1H-Pyrrol-1-yl-3-pyridazinamines.
    Bellasio E; Campi A; Di Mola N; Baldoli E
    J Med Chem; 1984 Aug; 27(8):1077-83. PubMed ID: 6747991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a new antihypertensive pyrrolyl pyridazinamine (MDL-899) in the rat and the dog.
    Assandri A; Bellasio E; Bernareggi A; Cristina T; Perazzi A; Odasso G
    Arzneimittelforschung; 1985; 35(2):508-13. PubMed ID: 3855234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737): identification of an unusual N-acetylglucosamine conjugate in the cynomolgus monkey.
    Johnson BM; Kamath AV; Leet JE; Liu X; Bhide RS; Tejwani RW; Zhang Y; Qian L; Wei DD; Lombardo LJ; Shu YZ
    Drug Metab Dispos; 2008 Dec; 36(12):2475-83. PubMed ID: 18787055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biotransformation of pyridazines. 1. Pyridazine and 3-methylpyridazine].
    Borchert HH; Pfeifer S; Helbig B; Franke P; Heinisch G
    Pharmazie; 1989 Sep; 44(9):625-30. PubMed ID: 2608708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and pharmacokinetics of cadralazine and individual metabolites in man.
    Schütz H; Faigle JW; Küng W; Theobald W
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):147-53. PubMed ID: 4043143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timolol metabolism in man and laboratory anamals.
    Tocco DJ; Duncan AE; deLuna FA; Smith JL; Walker RW; Vandenheuvel WJ
    Drug Metab Dispos; 1980; 8(4):236-40. PubMed ID: 6105057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
    Erve JC; Vashishtha SC; DeMaio W; Talaat RE
    Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolites of [3-13C]1,2-dibromo-3-chloropropane in male rats studied by 13C and 1H-13C correlated two-dimensional NMR spectroscopy.
    Dohn DR; Graziano MJ; Casida JE
    Biochem Pharmacol; 1988 Sep; 37(18):3485-95. PubMed ID: 3421999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
    Mutlib AE; Jurcak J; Hrib N
    Drug Metab Dispos; 1996 Oct; 24(10):1139-50. PubMed ID: 8894517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution NMR spectroscopic studies on the metabolism and futile deacetylation of 4-hydroxyacetanilide (paracetamol) in the rat.
    Nicholls AW; Caddick S; Wilson ID; Farrant RD; Lindon JC; Nicholson JK
    Biochem Pharmacol; 1995 Apr; 49(8):1155-64. PubMed ID: 7748197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Elimination of p-brom-hydrazino-pyridazine and of p-brom-phenyl-hydrazino-pyridazine from the body].
    Gafiţeanu E; Stefănescu E; Mocanu R; Petrovanu M
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(3):703-6. PubMed ID: 4453699
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotransformation of mianserin in laboratory animals and man.
    Delbressine LP; Moonen ME; Kaspersen FM; Jacobs PL; Wagenaars GL
    Xenobiotica; 1992 Feb; 22(2):227-36. PubMed ID: 1632112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo metabolism of 3-oxo-5-benzylidene-6-methyl-(4H)-2-(benzoylmethyl)pyridazine in rats.
    Oruç EE; Unsal O; Balkan A; Ozkanli F; Gören MZ; Terzioğlu B; Rollas S
    Eur J Drug Metab Pharmacokinet; 2006; 31(1):21-5. PubMed ID: 16715779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discovery.
    Teffera Y; Choquette D; Liu J; Colletti AE; Hollis LS; Lin MH; Zhao Z
    Chem Res Toxicol; 2010 Nov; 23(11):1743-52. PubMed ID: 20825217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.